Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 72 users online. 7 members and 65 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

48 results in 0.0078 seconds.
Keywords
Members
Tags
vaccine x
  •  

  • Walgreens Expects to Complete Administration of COVID-19 Vaccine First Doses in Skilled Nursing Facilities by January 25

    Walgreens Expects to Complete Administration of COVID-19 Vaccine First Doses in Skilled Nursing Facilities by January 25 | site |


    Walgreens continues to accelerate access to COVID-19 vaccinations among additional vulnerable populations as part of state and local jurisdictions distribution plans


    (Information contained in Walgreens press release dated: January 6, 2021)

    Deerfield, Ill., January 06, 2021 - Walgreens expects to complete the administration of COVID-19 vaccine first doses in skilled nursing facilities by Monday, Jan. 25. The company is also rapidly expanding access to vaccinations among assisted living facilities and additional vulnerable populations outlined by states and local jurisdictions as part of expanded distribution plans. “Since receiving our first allotments of vaccines in late December, Walgreens has remained on track in vaccinating our most vulnerable populations, and we are steadfast in our comm
    ...
    See more | Go to post

  • U.S. Department of Veterans Affairs administers over 146,000 COVID-19 Vaccine Doses to date

    U.S. Department of Veterans Affairs administers over 146,000 COVID-19 Vaccine Doses to date | site |



    (Information contained in U.S. Department of Veterans Affairs press release dated: January 5, 2021)

    Washington - - The U.S. Department of Veterans Affairs (VA) announced today it has administered initial COVID-19 vaccine doses to more than 14,000 Veterans at high risk of getting COVID-19 infection, and more than 132,000 health care employees as of Jan. 4.

    In accordance with VA’s COVID-19 Vaccine Distribution Plan, the department started vaccination efforts at 37 initial VA medical centers, following the Food and Drug Administration’s Dec. 11 decision to issue an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine. The 37 initial sites to first receive the vaccine were selected based on several factors, including having the capacity to store the vaccine at extremely cold temperatures and the ability to offer hi
    ...
    See more | Go to post

  • National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes

    National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes | site |



    NIH says "Data from Phase 3 clinical trial confirm vaccine is effective".


    (Information contained in National Institutes of Health [NIH] press release dated: December 30, 2020)

    The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD). The vaccine was co-developed by Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. ...
    See more | Go to post

  • U.S. Department of Veterans Affairs Administers over 55,000 COVID-19 Vaccine Doses in two Weeks

    U.S. Department of Veterans Affairs Administers over 55,000 COVID-19 Vaccine Doses in two Weeks | site |



    (Information contained in U.S. Department of Veterans Affairs press release: December 30, 2020)

    Washington - - The U.S. Department of Veterans Affairs (VA) announced today that it has administered initial COVID-19 vaccine doses to more than 5,000 Veterans residing in its Community Living Centers and Spinal Cord Injury and Disorders Centers and more than 50,000 health care employees in its first two weeks (Dec. 14-Dec. 27) of providing COVID-19 vaccines.

    VA began vaccinating Veterans and frontline employees at 37 initial VA medical centers according to its COVID-19 Vaccine Distribution Plan, following the Food and Drug Administration’s Dec. 11 decision to issue an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine. The 37 initial sites to first receive the vaccine were selected based on several factors, in
    ...
    See more | Go to post

  • UPS Statement - - - UPS Making First Deliveries of the Vaccine to the European Union

    UPS Statement: UPS Making First Deliveries of the Vaccine to the European Union | site |



    (Information contained in UPS press release dated: December 26, 2020)

    Brussels - - UPS (NYSE: UPS) is delivering the first doses of the Pfizer-BioNTech COVID-19 vaccines in the European Union today. The deliveries follow historic rollouts in North America and the Middle East, marking another breakthrough milestone in the response against the COVID-19 pandemic.



    Statement By Scott Price, President, UPS International;

    “UPS has proudly delivered the first doses of vaccines to the European Union, offering hope and health to citizens across the continent.

    During a period of unparalleled activity, our extensive expertise in healthcare logistics has allowed us to develop new products and approaches ensuring we deliver what matters most at the right time, at the right temperature, to communities all over the world.”
    ...
    See more | Go to post

  • COVID Vaccine Updates for Pilots

    COVID Vaccine Updates for Pilots

    COVID Vaccine Updates for Pilots | site |



    (Information contained in Air Line Pilots Association [ALPA] press release: December 28, 2020)

    ALPA continues to receive calls and DARTs from members asking the status of flight crews taking COVID-19 vaccines.

    In addition to working with the Federal Aviation Administration (FAA) and Transport Canada (TC) for swift approval for pilots to be vaccinated, ALPA has also been working to get flight crews voluntary access to vaccines once they receive government approval and are available to essential workers.




    In the United States


    On December 11, the Food and Drug Administration (FDA) granted an emergency use authorization (EUA) for the Pfizer-BioNTech vaccine. On December 12, the FAA Office of Aerospace Medicine adopted a policy change allowing the use of the Pfizer-BioNTech vaccine for holders of FAA-issued Airman Medical Certificates or Medical Clearances...
    See more | Go to post

  • NIH says Phase 3 Trial of Novavax Investigational COVID-19 Vaccine opens

    NIH says Phase 3 Trial of Novavax Investigational COVID-19 Vaccine opens

    National Institutes of Health says Phase 3 Trial of Novavax Investigational COVID-19 Vaccine opens| site |



    NIH- and BARDA-funded trial will enroll up to 30,000 volunteers.



    People 18 years of age and older who are interested in participating in this trial can visit coronaviruspreventionnetwork.org , ClinicalTrials.gov and search identifier NCT04611802, or Novavax.com/PREVENT-19 for details. Please do not contact the NIAID media phone number or email to enroll in this trial.



    (Information contained in National Institutes of Health [NIH] press release: December 28, 2020)

    The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled trial will enroll approximately 30,000 people at approximately 115 sites in the United States and Mexico. It will evaluate the safety and efficacy of NVX-CoV2373, a vaccine candidate...
    See more | Go to post

  • Walgreens Begins Administration of Pfizer’s COVID-19 Vaccine in Long-Term Care Facilities

    Walgreens Begins Administration of Pfizer’s COVID-19 Vaccine in Long-Term Care Facilities | site |



    Walgreens Plans to Administer the Vaccine to Approximately 3 Million Residents and Staff in 35,000 Long-Term Care Facilities as Part of the Centers for Disease Control and Prevention Program


    (Information contained in Walgreens press release dated: December 18, 2020)

    Deerfield, Ill., December 18, 2020 - Today Walgreens began administering Pfizer’s COVID-19 vaccine to residents and staff at long-term care facilities in a monumental first in the company’s 119-year history. Pharmacists are providing the vaccinations at nursing homes and assisted living facilities in Ohio and Connecticut as part of the Centers for Disease Control and Prevention (CDC) Pharmacy Partnership for Long-term Care Program. Walgreens pharmacy team members will provide COVID-19 vaccinations in approximately 800 long-term care facilities across 12 s...
    See more | Go to post

  • UPS Continues Support Of COVID-19 Vaccine Distribution

    UPS Continues Support Of COVID-19 Vaccine Distribution

    UPS Continues Support Of COVID-19 Vaccine Distribution | site |


    UPS Partners with McKesson to Transport and Deliver the Moderna COVID-19 Vaccine


    (Information contained in UPS press release dated: December 18, 2020) Atlanta, GA - - UPS (NYSE:UPS) continues its involvement with COVID-19 vaccine delivery efforts through a partnership with global pharmaceutical and medical supply distributor McKesson. Through contracts with the Centers for Disease Control and Prevention and the Assistant Secretary for Preparedness and Response to support Operation Warp Speed, McKesson is the centralized distributor for non-ultra-frozen COVID-19 vaccines and ancillary supply kits. Under its agreement with McKesson, UPS will begin delivering Moderna’s COVID-19 vaccine, which today received a U.S. Food and Drug Administration Emergency Use Authorization. “This is a critically important initiative for UPS, and we are committed to delivering what matters for as lon...
    See more | Go to post

  • American Medical Association urges Social Media Companies to Combat Vaccine Misinformation

    American Medical Association urges Social Media Companies to Combat Vaccine Misinformation | site |


    (Information contained in American Medical Association [AMA] press release dated: December 21, 2020) Chicago - - As the United States begins an unprecedented effort to administer COVID-19 vaccines to more than 300 million Americans, the American Medical Association (AMA) today urged the CEOs of six leading social media and e-commerce companies to assist the effort by combatting misinformation and disinformation about the vaccine on their platforms. The AMA also urged the platforms to share timely, accurate information on the vaccine from trusted public health institutions, including the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention. The letter was sent to the top executives at Google, Facebook, Instagram, Twitter, TikTok, and YouTube. “As we work tirelessly to stop the spread of COVID-19, please remain vigilant against...
    See more | Go to post

  • Trump Administration Purchases additional 100 Million Doses of COVID-19 Investigational Vaccine from Pfizer

    Trump Administration Purchases additional 100 Million Doses of COVID-19 Investigational Vaccine from Pfizer | site |


    (Information contained in U.S. Department of Health and Human Services press release: December 23, 2020) The Trump Administration, through the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD), will purchase an additional 100 million doses of COVID-19 vaccine from Pfizer. On Dec. 11, the U.S. Food and Drug Administration (FDA) authorized the vaccine for emergency use and doses began shipping immediately. The vaccine is being provided at no cost to Americans. Vaccine administration costs for private-sector administration partners are covered by healthcare payers: private insurance, Medicare or Medicaid, and HHS’s program to cover COVID-19 costs for the uninsured which is reimbursing the provider at Medicare rates from the provider relief fund. Under the agreement, Pfizer will manufacture and deliver up to 100 m...
    See more | Go to post

  • Media Statement from CDC Director Robert R. Redfield on Vaccine Milestone

    Media Statement from CDC Director Robert R. Redfield on Vaccine Milestone

    Media Statement from Centers for Disease Control and Prevention Director Robert R. Redfield on Vaccine Milestone | site |



    (Information contained in Centers for Disease Control and Prevention [CDC] press release media statement: December 23, 2020)



    Media Statement from CDC Director Robert R. Redfield on Vaccine Milestone


    The United States achieved an early but important milestone today – jurisdictions have now reported that more than 1 million people have received their first dose of COVID-19 vaccine since administration began 10 days ago. With cases of COVID-19 continuing to surge nationwide, this achievement comes at a critical time and will help to protect those on the frontlines – our healthcare providers treating COVID-19 patients – as well as our most vulnerable: elder individuals living in nursing homes and assisted living facilities. While we celebrate this historic milestone, we also acknowledge the...
    See more | Go to post

  • U.S. Department of Health and Human Services publishes Statements on FDA Authorization of Moderna Vaccine

    U.S. Department of Health and Human Services publishes Statements on FDA Authorization of Moderna Vaccine | site |



    (The following information was contained in a U.S. Department of Health and Human Services [HHS] press release dated: December 18, 2020)



    HHS and DoD Statements on FDA Authorization of Moderna Vaccine



    On Friday, the Food and Drug Administration announced that it had issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, the second COVID-19 vaccine to receive an EUA. Operation Warp Speed has allocated more than 5.9 million doses of the vaccine for jurisdictions to receive in the coming week. Below are statements from HHS Secretary Alex Azar and Acting Defense Secretary Christopher Miller. “On January 7, before China had reported even one death from the novel coronavirus or confirmed human-to-human transmission, NIH scientists and innovators at Moderna agreed to b...
    See more | Go to post

  • NIH publishes Statement on the FDA Emeregency Use Authorization of the Moderna COVID-19 Vaccine

    National Institutes of Health publishes Statement on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine| site |


    (The following is information contained in a National Institutes of Health [NIH] press release dated: December 18, 2020)


    Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine


    Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, for its COVID-19 vaccine, which was co-developed with scientists at the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). This innovative and monumental partnership has enabled NIH and Moderna to develop a safe and effective COVID-19 vaccine within the span of a year that will be manufactured and distributed across the U.S. The vaccine, called mRNA-1273, is a messenger...
    See more | Go to post

  • FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine

    U.S. Food and Drug Administration Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine | site |


    FDA says "Action Follows Thorough Evaluation of Available Safety, Effectiveness, and Manufacturing Quality Information by FDA Career Scientists, Input from Independent Experts"


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: December 18, 2020) Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. “With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    Walgreens Expects to Complete Administration of COVID-19 Vaccine First Doses in Skilled Nursing Facilities by January 25
    by Staff Reporter 1
    Walgreens Expects to Complete Administration of COVID-19 Vaccine First Doses in Skilled Nursing Facilities by January 25 | site |


    Walgreens continues to accelerate access to COVID-19 vaccinations among additional vulnerable populations as part of state and local jurisdictions distribution plans


    (Information contained in Walgreens press release dated: January 6, 2021)

    Deerfield, Ill., January 06, 2021 - Walgreens expects to complete the administration of COVID-19 vaccine first doses in skilled nursing facilities by Monday, Jan. 25. The company is also rapidly expanding access to vaccinations among assisted living facilities and additional vulnerable populations outlined by states and local jurisdictions as part of expanded distribution plans. “Since receiving our first allotments of vaccines in late December, Walgreens has remained on track in vaccinating our most vulnerable populations, and we are steadfast in our comm
    ...
    01-11-2021, 10:02 PM
  • Staff Reporter 1
    U.S. Department of Veterans Affairs administers over 146,000 COVID-19 Vaccine Doses to date
    by Staff Reporter 1
    U.S. Department of Veterans Affairs administers over 146,000 COVID-19 Vaccine Doses to date | site |



    (Information contained in U.S. Department of Veterans Affairs press release dated: January 5, 2021)

    Washington - - The U.S. Department of Veterans Affairs (VA) announced today it has administered initial COVID-19 vaccine doses to more than 14,000 Veterans at high risk of getting COVID-19 infection, and more than 132,000 health care employees as of Jan. 4.

    In accordance with VA’s COVID-19 Vaccine Distribution Plan, the department started vaccination efforts at 37 initial VA medical centers, following the Food and Drug Administration’s Dec. 11 decision to issue an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine. The 37 initial sites to first receive the vaccine were selected based on several factors, including having the capacity to store the vaccine at extremely cold temperatures and the ability to offer hi
    ...
    01-07-2021, 08:07 AM
  • Staff Reporter 1
    National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes
    by Staff Reporter 1
    National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes | site |



    NIH says "Data from Phase 3 clinical trial confirm vaccine is effective".


    (Information contained in National Institutes of Health [NIH] press release dated: December 30, 2020)

    The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD). The vaccine was co-developed by Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. ...
    01-02-2021, 07:44 PM
  • Staff Reporter 1
    U.S. Department of Veterans Affairs Administers over 55,000 COVID-19 Vaccine Doses in two Weeks
    by Staff Reporter 1
    U.S. Department of Veterans Affairs Administers over 55,000 COVID-19 Vaccine Doses in two Weeks | site |



    (Information contained in U.S. Department of Veterans Affairs press release: December 30, 2020)

    Washington - - The U.S. Department of Veterans Affairs (VA) announced today that it has administered initial COVID-19 vaccine doses to more than 5,000 Veterans residing in its Community Living Centers and Spinal Cord Injury and Disorders Centers and more than 50,000 health care employees in its first two weeks (Dec. 14-Dec. 27) of providing COVID-19 vaccines.

    VA began vaccinating Veterans and frontline employees at 37 initial VA medical centers according to its COVID-19 Vaccine Distribution Plan, following the Food and Drug Administration’s Dec. 11 decision to issue an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine. The 37 initial sites to first receive the vaccine were selected based on several factors, in
    ...
    12-31-2020, 04:38 AM
  • Staff Reporter 1
    UPS Statement - - - UPS Making First Deliveries of the Vaccine to the European Union
    by Staff Reporter 1
    UPS Statement: UPS Making First Deliveries of the Vaccine to the European Union | site |



    (Information contained in UPS press release dated: December 26, 2020)

    Brussels - - UPS (NYSE: UPS) is delivering the first doses of the Pfizer-BioNTech COVID-19 vaccines in the European Union today. The deliveries follow historic rollouts in North America and the Middle East, marking another breakthrough milestone in the response against the COVID-19 pandemic.



    Statement By Scott Price, President, UPS International;

    “UPS has proudly delivered the first doses of vaccines to the European Union, offering hope and health to citizens across the continent.

    During a period of unparalleled activity, our extensive expertise in healthcare logistics has allowed us to develop new products and approaches ensuring we deliver what matters most at the right time, at the right temperature, to communities all over the world.”
    ...
    12-30-2020, 05:01 AM

Menu

Collapse

Menu

Collapse

Working...
X